Experts believe artificial intelligence will lead to more efficiency and quality across all aspects of healthcare. And it may have a positive impact in rural communities in the developing world. More
Bio & Life Sciences Healthcare
Why Do Kids Get Cancer? Promising Research is Underway.
Understanding how an old person’s disease develops in kids could offer clues about how to predict, or maybe even prevent, pediatric cancers. More
The Internet of (Medical) Things Moment is Here
The global Internet of Medical Things market's value will reach $158 billion by 2022. But IoMT is already changing health care. More
Tech Startups Build Tools for Wellness
Technology now allows us to monitor, promote, augment, and manage our well-being. Analyst Owyang pioneers here a new chart that outlines the entire industry, which is of impressive size already. Digitized low-cost technologies will make wellness accessible to anyone. More
Digital Health is Complicated
Haunting stories out of Facebook are contrasted with a pro-mental health initiative by Instagram; Uber and Lyft are planning to save the health care industry billions; and the eradication of polio is in the hands of lab technicians. This week in digital health news. More
Bio & Life Sciences Healthcare Science
Why Thursday Is Rare Disease Day
With the exception of primetime medical dramas, you don’t hear much about rare diseases. But just because they’re “rare” — in the U.S., that’s a guideline used for diseases affecting fewer than 200,000 Americans — doesn’t mean they’re scarce. Rare Disease Day, held this year on February 28th, raises awareness for rare diseases and reminds us that these conditions have an outsize impact. More
Telemedicine Could Fix Our Broken Healthcare System
The U.S. does not get sufficient bang for all the bucks it spends on healthcare – the highest percentage of GDP in the world. But telemedicine can contribute to major progress, says Philips U.S. CEO Vitor Rocha. More
Bio & Life Sciences Healthcare Opinion
Skeptics Unfairly Target UK Gene Sequencing Initiative
A new UK initiative has stirred debate about DNA analysis for healthy people. The program allows patients to pay to get their genome sequenced and analyzed if they agree to let the data be used in research. Author Salisbury says the UK controversy largely misses the point. More
You Bet Your Life
With consumer skepticism soaring, the tech giants move into healthcare. (From the latest Techonomy Magazine) More
Daniel Kraft: ‘Sick-Care’ Could Finally Become Healthcare
In a wide-ranging look at how exponential technologies could change the face of healthcare, Daniel Kraft, faculty chair of medicine and neuroscience at Singularity University, told Techonomy 2018 attendees Sunday that personalized medicine is on our doorstep, from wearables to "printed" medications. More
Bio & Life Sciences Healthcare
Genomic Study Offers Hope for Millions with Rare Diseases
A new study makes the case that genomic medicine can be cost effective in diagnosing rare diseases, offering a potential alternative path for millions of patients worldwide. More
Insurance Roadblocks Threaten to Limit Use of Genomic Tests
Resistance from insurance companies threatens to slow innovation that could dramatically improve patient outcomes from genomic testing. More
Biomedical Innovation Gaining Ground in Singapore
Twenty years of investment in biomedical infrastructure and innovation is starting to pay off for Singapore. More
Bio & Life Sciences Healthcare
Critical Genomic Breakthrough Should Help Identify Disease Risk
A new report suggests that an innovative method of analyzing DNA will allow medical researchers to predict disease risk for far more people than can be done with conventional medical tests. More
Bio & Life Sciences Healthcare Opinion
Why I Joined a Research Study — and You Should Too
In which our intrepid reporter gives her very blood to stay on the front lines of modern healthcare. More
Asia’s Cancer Crisis Inspires Lab Innovation
The growing number of cancer patients in Asia is spurring innovative research and development — and some promising diagnostic developments. More
Missing From Clinical Trials: the Patient Perspective
The design and execution of clinical trials represents an ideal opportunity to engage the consumer and begin building a relationship that can last a lifetime. More
Bio & Life Sciences Healthcare
New Cancer Concerns Shake Up CRISPR Prognosis
New studies connect gene editing with CRISPR technology to cancer, sending stocks plummeting and raising serious questions about the technology's potential. More
Could the Facebook Scandal Slow Down Digital Healthcare?
In the wake of the Facebook data breach, consumer concerns over data security could slow the growth of digital health. Blockchain may be a solution. More
Techonomy NYC: With Precision Medicine, Every Disease will be a ‘Rare Disease’
There are an estimated 7,000 rare diseases known today, collectively affecting some 350 million people around the world. Big data, AI, and smart records bring hope. More
Newsletter